145 related articles for article (PubMed ID: 166922)
1. Inhibition of Herpesvirus hominis replication by human interferon.
Rasmussen L; Farley LB
Infect Immun; 1975 Jul; 12(1):104-8. PubMed ID: 166922
[TBL] [Abstract][Full Text] [Related]
2. Effect of human leukocyte interferon on vaccinia-and herpes virus-infected cell cultures and monkey corneas.
Neumann-Haefelin D; Sundmacher R; Sauter B; Karges HE; Manthey KF
Infect Immun; 1975 Jul; 12(1):148-55. PubMed ID: 166924
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures.
Youngner JS; Thacore HR; Kelly ME
J Virol; 1972 Aug; 10(2):171-8. PubMed ID: 4342236
[TBL] [Abstract][Full Text] [Related]
4. Production of interferon by long-term suspension cultures of leukocytes derived from patients with viral and nonviral diseases.
Minnefor AB; Halsted CC; Seto DS; Glade PR; Moore GE; Carver DH
J Infect Dis; 1970 Apr; 121(4):442-4. PubMed ID: 4315000
[No Abstract] [Full Text] [Related]
5. Antiviral activity in interferon-treated bovine tracheal organ cultures.
Fulton RW; Root SK
Infect Immun; 1978 Aug; 21(2):672-3. PubMed ID: 211089
[TBL] [Abstract][Full Text] [Related]
6. Interferon induction in rabbit and human tears.
Centifanto YM; Goorha RM; Kaufman HE
Am J Ophthalmol; 1970 Dec; 70(6):1006-9. PubMed ID: 4321443
[No Abstract] [Full Text] [Related]
7. Interferon system of human cornea cells: interferon production, characterization, and development of antiviral state.
Thacore HR; Mount DT; Chadha KC
J Interferon Res; 1982; 2(3):401-8. PubMed ID: 6182255
[TBL] [Abstract][Full Text] [Related]
8. PERSISTENT INFECTION OF HUMAN CONJUNCTIVA CELL CULTURES BY MYXOVIRUS PARAINFLUENZA 3.
COLE FE; HETRICK FM
Can J Microbiol; 1965 Jun; 11():513-21. PubMed ID: 14346128
[No Abstract] [Full Text] [Related]
9. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins.
Wallach D
J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250
[TBL] [Abstract][Full Text] [Related]
10. Specific role of each human leukocyte type in viral infections. I. Monocyte as host cell for vesicular stomatitis virus replication in vitro.
Edelman R; Wheelock EF
J Virol; 1967 Dec; 1(6):1139-49. PubMed ID: 4316248
[TBL] [Abstract][Full Text] [Related]
11. Persistence of the viral genome in interferon-treated cells infected with oncogneic or nononcogenic viruses.
Friedman RM; Costa JC; Ramseur JM; Meyers MW; Jay FT; Chang EH
J Infect Dis; 1976 Jun; 133 Suppl():A43-50. PubMed ID: 180209
[TBL] [Abstract][Full Text] [Related]
12. Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells.
Borghi P; Di Marzio P; Varano B; Conti L; Belardelli F; Gessani S
J Gen Virol; 1992 Nov; 73 ( Pt 11)():2949-54. PubMed ID: 1279103
[TBL] [Abstract][Full Text] [Related]
13. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
Maheshwari RK; Friedman RM
J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons.
Ito Y; Montagnier L
Infect Immun; 1977 Oct; 18(1):23-7. PubMed ID: 198374
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
Maheshwari RK; Jay FT; Friedman RM
Science; 1980 Feb; 207(4430):540-1. PubMed ID: 6243416
[TBL] [Abstract][Full Text] [Related]
16. Effect of exogenous tumor necrosis factor alpha, interleukin 6 and interferons on vesicular stomatitis virus replication in human placenta and amniotic membrane organ cultures.
Paradowska E; Blach-Olszewska Z; Gierlińska M; Woytoń J
Arch Immunol Ther Exp (Warsz); 1996; 44(1):57-62. PubMed ID: 8874771
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus susceptibility to human interferon during one-step replication.
Gallagher JG; Khoobyarian N
Infect Immun; 1972 Jun; 5(6):905-8. PubMed ID: 4344095
[TBL] [Abstract][Full Text] [Related]
18. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
[TBL] [Abstract][Full Text] [Related]
19. Studies of L cells persistently infected with VSV: factors involved in the regulation of persistent infection.
Nishiyama Y
J Gen Virol; 1977 May; 35(2):265-79. PubMed ID: 195007
[TBL] [Abstract][Full Text] [Related]
20. Factors affecting the sensitivity of different viruses to interferon.
Hallum JV; Thacore HR; Youngner JS
J Virol; 1970 Aug; 6(2):156-62. PubMed ID: 4322869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
